Commercialization: Page
-
Competitive Intelligence: The Eyes and Ears of the Industry
The need to gain a competitive advantage has never been greater, and competitive-intelligence (CI) teams are evolving to meet the industry’s current and future challenges. Shrinking pipelines, increased regulatory scrutiny, and the emergence of clinical-trial registries are just a few of the fact...
By PharmaVoice Team • Jan. 2, 2008 -
In the Clinic: Trials & Tribulations
Stakeholders involved with drug development and the clinical-trial process are rising to the challenges to improve efficiencies, reduce costs, and accelerate time lines. Systematic elegant approaches borrowing from areas such as intelligence analysis are at hand. Enhanced product characterization...
By PharmaVoice Team • Jan. 2, 2008 -
Year in Preview -- Thought Leaders
Thought Leaders Listed in Alphabetical Order December 2005 Year in Preview 2006 Meredith Abreu. VP of Research, Manhattan Research LLC, New York; Manhattan Research is a provider of health and pharmaceutical marketing research and strategic analysis. For more information, visit manhattanresearch....
By PharmaVoice Team • Jan. 2, 2008 -
The Management of Customer Relationship Management
The Management of Customer Relationship Management By Elisabeth Pena Villarroel Responding to the customers’ needs is more important than ever for pharmaceutical companies. As patients seek more information and doctors continue to be crunched for time, targeted, meaningful messages that add...
By PharmaVoice Team • Jan. 2, 2008 -
Talent Pool
Pharma POOL Louis C. Arp Dr. Lyn D. Olson Eisai Announces Executive Appointments Eisai, a pharmaceutical company based in Teaneck, N.J., has appointed Louis C. Arp as VP of production operations and Lyn D. Olson, Ph.D., as VP of quality at its pharmaceutical production and formulation research an...
By PharmaVoice Team • Jan. 2, 2008 -
Talent Pool
Talent Pool PharmaVOICE October 2005 Executive Appointments and Promotions in the Healthcare Industry Pharma POOL Dr. Jacqueline Crew Paul Medeiros Dr. John O’Mullane David Wing Schering-Plough Adds Executive Leadership Schering-Plough, a global science-based healthcare company bas...
By PharmaVoice Team • Jan. 2, 2008 -
Pharma's Opportunity: Branding for the Long Haul
Branding Pharma’s Opportunity: Branding for the Long Haul By Kristen Spensieri The vital importance of branding has long been standard practice in the consumer marketplace, with the most successful companies creating brands that stand for infinitely more than individual products or, in som...
By PharmaVoice Team • Jan. 2, 2008 -
What Do You Look for in a Widget?
What Do You Look for in a Widget? Warren A. Dardine President, Clinical Education Associates, a division of Dimensional HealthCare Inc. Suppose you were in the market to buy a new widget. You would probably read manufacturer information regarding the superiority of the newer widget compar...
By PharmaVoice Team • Jan. 2, 2008 -
Integrated Marketing Communications: Understanding the Premise, Fulfilling the Promise
Integrated Marketing Communications: Understanding the Premise, Fulfilling the Promise Gary Bridi, Managing Director, S&H NJ Integrated marketing communications (IMC) is not a new idea. But while it has been discussed in academic and industry circles since the early 90s, its full benefi...
By PharmaVoice Team • Jan. 2, 2008 -
E-Media
New Electronic and Web-based Applications, Sites, and Technologies E-media PhRMA Website Educates Consumers on the Risks of Importing Drugs Citing a growing body of information that opening the U.S. borders to foreign drugs is risky and unsafe, the Pharmaceutical Research and Manufact...
By PharmaVoice Team • Jan. 2, 2008 -
The Agency Account Executive and the Industry Product Manager: Two Sides of the Same Coin
Mark Perlotto, Executive VP, General Manager The Agency Account Executive and the Industry Product Manager: Two Sides of the Same Coin People often draw an imaginary line between “agency people” and “industry people” — believing that individuals are cut out for one “side” or the other. Whi...
By PharmaVoice Team • Jan. 2, 2008 -
Driving Sales with Data
Pharmaceutical and device manufacturers are constantly seeking new ways to better communicate the value of their products. Phase IV studies have been the typical means to confirm clinical safety and efficacy, and to understand what happens in “real-world” settings. But, according to F. Randy Voge...
By PharmaVoice Team • Jan. 2, 2008 -
Letter from the Editor
The spirit of giving Fifth Annual PharmaLinx Charity Golf Outing Linda Beneze from PHT Corp., a gold sponsor of the event, and Taren Grom, editor of PharmaVOICE, take a moment during the Fifth Annual PharmaLinx Charity Golf Outing. The pharmaceutical and life-sciences industries have on...
By PharmaVoice Team • Jan. 2, 2008 -
On the Calendar
Industry Event On the Calendar PharmaVOICE October 2005 October 17-18 3rd Annual Mid-Market Healthcare M&A & Corporate Development Conference Loews Vanderbilt Hotel, Nashville, Tenn. For more information, contact Sandro Pardo, Strategic Research Institute, at 212-967-0095 x234, e-mail spa...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaOutlet
Patients’ Channel Preferences Vary by Personal Situation In the past few years, patients have become increasingly more informed and sophisticated. They continue to experience increased time pressures and have more access to information about prescription brands than ever thanks to the Internet. T...
By David Zaritsky and Julian Parreño • Jan. 2, 2008 -
PharmaTrax
Internet Deemed the Most Trusted Media Source by Healthcare Consumers A new study of consumer attitudes toward healthcare information finds that the Internet is regarded as the most trusted media source for consumers, decisively outstripping offline media when consumers want credible health infor...
By PharmaVoice Team • Jan. 2, 2008 -
Kevin Hrusovsky -- Bucking the Trend
Kevin Hrusovsky — Bucking the Trend By Kim Ribbink From the playing fields to football fandom to building teams to the corporate boardroom, Kevin Hrusovsky carries an infectious enthusiasm for everything he does. And it’s that energy that is helping to drive innovation at Caliper Life Sciences. “...
By Kim Ribbink • Jan. 2, 2008 -
Exit Pied Piper. Enter Johnny Appleseed.
Exit Pied Piper. Enter Johnny Appleseed. 4 Reasons to Embrace Personalized Communication While Preparing for Personalized Medicine Eve Dryer President, Vox Medica Healthcare Public Relations Chief Strategy Officer/Senior VP, Vox Medica Pharmaceutical compa...
By PharmaVoice Team • Jan. 2, 2008 -
Let the Science Tell the Story
Communications Larry Wright, Ph.D. VP, Account Services and Business Development The molecular science involved in creating an agent, as well as the biological rationale for the agent’s use intrigues that “little bit of biologist” in each and every healthcare profes...
By PharmaVoice Team • Jan. 2, 2008 -
What's New
What’s New New healthcare-related products, services, and companies GfK Group Integrates U.S. Healthcare Businesses GfK Group has consolidated its U.S. healthcare activities under GfK U.S. HealthCare Companies. This move follows GfK’s acquisition of NOP World, as well as its full acquisition of G...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaTrax
PharmaTrax Cardiovascular Drug Market to Top $100 Billion by 2008 The worldwide market for prescription cardiovascular medications, which topped $75 billion in 2004, will surpass the $100 billion mark by 2008, according to a new report released by Kalorama Information titled The Worldwide M...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaOutlet
Contributed by Louise Anderson Time to Bundle Up Pharmaceutical companies are facing increased competition and are now taking a lead from other industries, such as telecommunications, and looking to a bundled sales approach. In so doing, the sales organizations are moving to a model of team selli...
By PharmaVoice Team • Jan. 2, 2008 -
Letter from the Editor
Medicare Part D is launching in a few months and is expected to pump $540 million in benefits over the next 10 years into the healthcare industry, making the government the largest purchaser in the United States. After a long buildup period, the marketing of Medicare Part D prescription drug b...
By PharmaVoice Team • Jan. 2, 2008 -
Letter from the Editor
The numbers are staggering: 70% of all medical prescriptions go unconsumed, leading to $77 billion in excess healthcare costs each year; 30% to 85% of patients may disregard refills, depending on the disease and treatment regimen; and up to 20% of all hospital and nursing home admissions and 125 ...
By Taren Grom • Jan. 2, 2008 -
Pharmaceutical Sales Rep Compensation: Time for an overhaul
A look at the minimum and maximum potential for each sales territory can give companies better insight into what their sales reps are actually contributing. This information can provide a way to devise new and fairer compensation patterns that will generate more motivation for sales reps and, ult...
By PharmaVoice Team • Jan. 2, 2008